<DOC>
	<DOCNO>NCT00050934</DOCNO>
	<brief_summary>This study evaluate safety effectiveness oxcarbazepine ( Trileptal ) add-on therapy treatment partial seizure pediatric patient 1 month 3 year age .</brief_summary>
	<brief_title>Pediatric Epilepsy Study</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>INCLUSION CRITERIA : To enter study , patient must : Have diagnosis partial seizure Be willing hospitalize Weigh minimum 6.6 pound Be take stable dose one two concomitant antiepileptic medication Have previous CAT scan/MRI confirm absence space occupy lesion progressive neurological disease Have normal laboratory result EXCLUSION CRITERIA : To enter study , patient must : Seizures cause metabolic disturbance , toxic exposure , active infection A primary diagnosis generalize epilepsy ( exception secondarily generalize seizure ) A history status epilepticus within 30 day Seizures relate epilepsy Frequent use additional antiepileptic medication treat increase seizure ( example : rectal diazepam ) Taking felbamate within 6 month Serum sodium level &lt; 135 mEq/L Significant heart , breathing , kidney , stomach , liver , blood , cancer disorder require treatment/therapy A history chronic infection ( e.g. , hepatitis HIV ) Significant electrocardiogram ( ECG ) abnormalities A nursing mother take anticonvulsant drug Previously demonstrate sensitivity/allergic reaction Trileptal related compound Used experimental medication within 30 day enter study</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>partial seizure</keyword>
</DOC>